These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25740706)

  • 1. FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.
    Liu Y; Ao X; Jia Z; Bai XY; Xu Z; Hu G; Jiang X; Chen M; Wu H
    Sci Rep; 2015 Mar; 5():8796. PubMed ID: 25740706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E; Irminger-Finger I
    Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.
    Eakin CM; Maccoss MJ; Finney GL; Klevit RE
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5794-9. PubMed ID: 17392432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BRCA1/BARD1 ubiquitin ligase and its substrates.
    Witus SR; Stewart MD; Klevit RE
    Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1.
    Deng J; Zhang T; Liu F; Han Q; Li Q; Guo X; Ma Y; Li L; Shao G
    Biochem Biophys Res Commun; 2022 Jun; 611():107-113. PubMed ID: 35487060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
    Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M; Schuechner S; Au WW; Henderson BR
    Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
    Xu J; Watkins T; Reddy A; Reddy ES; Rao VN
    Int J Oncol; 2009 Apr; 34(4):939-49. PubMed ID: 19287951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability.
    Liu F; Han Q; Zhang T; Chang F; Deng J; Huang X; Wang W; Xu Y; Li Q; Xu L; Zhang B; Li W; Li L; Su Y; Li Y; Shao G
    Int J Biol Sci; 2022; 18(4):1434-1450. PubMed ID: 35280675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
    Verma S; Yeddula N; Soda Y; Zhu Q; Pao G; Moresco J; Diedrich JK; Hong A; Plouffe S; Moroishi T; Guan KL; Verma IM
    Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7363-7370. PubMed ID: 30918126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
    Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
    Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.
    Shan L; Zhou X; Liu X; Wang Y; Su D; Hou Y; Yu N; Yang C; Liu B; Gao J; Duan Y; Yang J; Li W; Liang J; Sun L; Chen K; Xuan C; Shi L; Wang Y; Shang Y
    Cancer Cell; 2016 Nov; 30(5):708-722. PubMed ID: 27773593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1.
    Kim KH; Yoon JM; Choi AH; Kim WS; Lee GY; Kim JB
    Mol Endocrinol; 2009 Apr; 23(4):466-74. PubMed ID: 19164445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.
    Okino Y; Machida Y; Frankland-Searby S; Machida YJ
    J Biol Chem; 2015 Jan; 290(3):1580-91. PubMed ID: 25451922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrates of the BRCA1-dependent ubiquitin ligase.
    Starita LM; Parvin JD
    Cancer Biol Ther; 2006 Feb; 5(2):137-41. PubMed ID: 16479151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
    Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
    Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.
    Zhu Q; Huang J; Huang H; Li H; Yi P; Kloeber JA; Yuan J; Chen Y; Deng M; Luo K; Gao M; Guo G; Tu X; Yin P; Zhang Y; Su J; Chen J; Lou Z
    Nat Commun; 2021 Nov; 12(1):6653. PubMed ID: 34789768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HERC2 is an E3 ligase that targets BRCA1 for degradation.
    Wu W; Sato K; Koike A; Nishikawa H; Koizumi H; Venkitaraman AR; Ohta T
    Cancer Res; 2010 Aug; 70(15):6384-92. PubMed ID: 20631078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
    Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
    Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
    Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
    Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.